Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Ten Years Experiences of ATS Mechanical Valve

ATS 기계 판막의 10년 임상경험

  • Yi, Gi-Jong (Department of Thoracic and Cardiovascular Surgery, Yondong Severance Hospital, Yonsei University College of Medicine) ;
  • Bae, Mi-Kyung (Department of Thoracic and Cardiovascular Surgery, Yondong Severance Hospital, Yonsei University College of Medicine) ;
  • Lim, Sang-Hyun (Department of Thoracic and Cardiovascular Surgery, Yondong Severance Hospital, Yonsei University College of Medicine) ;
  • Yoo, Kyung-Jong (Department of Thoracic and Cardiovascular Surgery, Yondong Severance Hospital, Yonsei University College of Medicine) ;
  • Chang, Byung-Chul (Department of Thoracic and Cardiovascular Surgery, Yondong Severance Hospital, Yonsei University College of Medicine) ;
  • Hong, You-Sun (Department of Thoracic and Cardiovascular Surgery, Yondong Severance Hospital, Yonsei University College of Medicine)
  • 이기종 (연세대학교 의과대학 영동세브란스병원 흉부외과) ;
  • 배미경 (연세대학교 의과대학 영동세브란스병원 흉부외과) ;
  • 임상현 (연세대학교 의과대학 영동세브란스병원 흉부외과) ;
  • 유경종 (연세대학교 의과대학 영동세브란스병원 흉부외과) ;
  • 장병철 (연세대학교 의과대학 영동세브란스병원 흉부외과) ;
  • 홍유선 (연세대학교 의과대학 영동세브란스병원 흉부외과)
  • Published : 2006.12.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: This study is to evaluate the safety of ATS valve by examining the clinical results of ten-years experience. Material and Method: From July 1995 to March 2005, we reviewed 305 patients with ATS valve implantation. Mean age was $49.8{\pm}11.7$ years and 140(45.6%) males were included. Etiologies were rheumatic diseases in 207 cases(67.4%), degenerative changes in 57 cases(18.6%), valve dysfunction in 23 cases(7.5%) and infective endocarditis in 14 cases(4.6%). AVR was performed in 72 patients(23.5%), MVR in 156 patients (50.8%), DVR(AVR+MVR) in 63 patients(20.5%) and TVR in 16 patients(5.2%). Result: There were 9 operative mortalities(2.9%). Follow up period was $56.5{\pm}34.0(0{\sim}115)$ months and 96.4% patients were followed up with 9 late deaths. Five and ten years survival rates were $94.9{\pm}1.3%,\;91.2{\pm}2.3%$ using Kaplan-Meier's methods. Valve related event free survival rates in 5 and 10 years were $90.8{\pm}2.0%$ and $86.9{\pm}3.2%$. There were 16 anticoagulation-related hemorrhages, 6 thromboembolisms, 3 prosthetic valve endocarditis and 1 paravalvular leakage. NYHA class improved after operation(p<0.05). Postoperative echocardiography showed significant decrease in LA size, LVEDD and IVESD(p<0.01). Patients with 19 and 21 mm valve showed significantly higher transvalvular pressure gradient in aortic position(p<0.001, p<0.001). Conclusion: ATS valve showed good hemodynamic results with few valve related complications and thus can be used with acceptable risk.

배경: 저자들은 ATS 기계 판막의 10년간의 임상결과 및 판막 관련 합병증을 조사하여 해당 판막의 안정성을 평가하고자 하였다. 대상 및 방법: 1995년 7월부터 2005년 3월까지 ATS 인공판막으로 수술을 시행 받은 305명의 환자들을 대상으로 하였다. 환자들의 평균 나이는 $49.8{\pm}11.7$세였고 남자가 140명(45.6%)이었다. 판막 대치술의 원인으로는 류마티스성 판막질환이 207예(67.4%), 판막의 퇴행성 변화가 57예(18.6%, 이엽성 대동맥 판막 포함), 이전에 이식한 판막의 기능부전이 23예(7.5%),감염성 심내막염이 14예(4.6%) 등이었다. 시행했던 수술로는 대동맥판막 치환술이 72예(23.5%), 승모판막 치환술이 156예(50.8%), 이중판막 치환술(AVR+MVR)이 63예(20.5%), 삼첨판막 치환술을 포함한 경우가 16예(5.2%)였다. 결과: 수술 관련 사망은 9예 있었다(사망률; 2.9%). 추적 관찰 기간은 $56.5{\pm}34.0(0{\sim}115)$개월이었고 누적 추적 관찰률은 96.4%였으며, 이 중 9명의 환자가 만기 사망하였다. Kaplan-Meier 생존 분석을 이용한 5년과 10년의 통계 결과들은 생존율이 $94.9{\pm}1.3%,\;91.2{\pm}2.3%$였으며, 판막과 관련된 사건이 없을 확률은 $90.8{\pm}2.0%,\;86.9{\pm}3.2%$였다. 판막과 관련된 합병증으로는 출혈 관련 합병증이 16예로 가장 많았고, 혈전색전증 관련 합병증이 6예, 인공 판막 심내막염이 3예, 판막 변연부 누출이 1예 등이었다. 수술 후 환자들의 NYHA class는 유의하게 호전되었다(p<0.05). 심초음파로 측정한 수술 전후 심장 크기에 있어서는 좌심방과 확장기말 및 수축기말의 좌심실 크기 모두에 있어서 수술 후 유의한 감소를 확인할 수 있었다(p<0.01). 대동맥 판막 크기에 따른 판막 전후의 압력차에 관한 분석에서는 19 mm와 21 mm의 판막을 사용한 경우가 그보다 큰 판막을 사용한 경우에 비하여 유의하게 큰 것을 확인할 수 있었다(p<0.001, p<0.001). 결론: 10년간의 사용결과 ATS 인공판막은 우수한 혈역학적 결과와 함께 낮은 판막과 관련된 합병증의 빈도를 나타내었다. ATS 기계 판막은 임상적으로 비교적 안전하게 사용할 수 있는 판막이라고 생각된다.

Keywords

References

  1. Emery RW, Anderson RW, Lindsay WG, Jorgensen CR, Wang Y, Nicoloff DM. Clinical and hemodynamic results with the St. Jude medical aortic valve prosthesis. Surg Forum 1979;30:235-8
  2. Emery RW, Van Nooten GJ, Tesar PJ. The initial experience with the ATS medical mechanical cardiac valve prosthesis. Ann Thorac Surg 2003;75:444-52 https://doi.org/10.1016/S0003-4975(02)04537-X
  3. Westaby S, Van Nooten G, Sharif H. Valve replacement with the ATS open pivot bileaflet prosthesis. Eur J Cardiothorac Surg 1996;10:660-5
  4. Stefanidis C, Nana AM, De Canniere D, Antoine M, Jansens J, Le Clerc J. 10-year experience with the ATS mechanical valve in the mitral position. Ann Thorac Surg 2005;79:1934-8 https://doi.org/10.1016/j.athoracsur.2005.01.002
  5. Sezai A, Shiono M, Orime Y, Hata H, Yagi S, Sezai Y. Evaluation of valve sound and its effects on ATS prosthetic valves in patients' quality of life. Ann Thorac Surg 2000;69: 507-12 https://doi.org/10.1016/S0003-4975(99)01302-8
  6. Park KH, Park SW, Yoo JW, et al. Early clinical outcome and Doppler echocardiographic data after cardiac valve replacement with the ATS prosthesis. Korean J Thorac Cardiovasc Surg 1997;30:663-9
  7. Van Nooten G, Caes F, Francois K, Missault L, Van Belleg hem Y. Clinical experience with the first 100 ATS heart valve implants. Cardiovasc Surg 1996;4:288-92 https://doi.org/10.1016/0967-2109(95)00123-9
  8. Nicoloff DM, Friedberg HD, Villafana MA. ATS medical open pivot valve with low intensity anticoagulant therapy. Cardiovasc Surg 1996;4(Suppl 1):152-3
  9. Ratnatunga CP, Edwards MB, Dore CJ, Taylor KM. Tricuspid valve replacement: UK Heart Valve Registry mid-term results comparing mechanical and biological prostheses. Ann Thorac Surg 1998;66:1940-7 https://doi.org/10.1016/S0003-4975(98)01183-7
  10. Emery RW, Krogh CC, Arom KV, et al. The St. Jude medical cardiac valve prosthesis: a 25-year experience with single valve replacement. Ann Thorac Surg 2005;79:776-83 https://doi.org/10.1016/j.athoracsur.2004.08.047
  11. Kang CH, Ahn H, Kim KH, Kim KB. Long-term result of 1,144 CarboMedics mechanical valve implantations. Ann Thorac Surg 2005;79:1939-44 https://doi.org/10.1016/j.athoracsur.2004.12.028
  12. Van Nooten GJ, Caes F, Taeymans Y, et al. Tricuspid valve replacement: postoperative and long-term results. J Thorac Cardiovasc Surg 1995;110:672-9 https://doi.org/10.1016/S0022-5223(95)70098-6
  13. Yoganathan AP, Chaux A, Gray RJ, et al. Bileaflet tilting disc and porcine aortic valve substitutes: in vitro hydrodynamic characteristics. J Am Coll Cardiol 1984;3:313-20 https://doi.org/10.1016/S0735-1097(84)80014-5
  14. Rahimtoola SH. Valve prosthesis-patient mismatch: an update. J Heart Valve Dis 1998;7:207-10
  15. Pibarot P, Dumesnil JG. Hemodynamic and clinical impact of prosthesis -patient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol 2000;36:1131-41 https://doi.org/10.1016/S0735-1097(00)00859-7
  16. Sim EKW, Orszulak TA, Schaff HV, Shub C. Influence of prosthesis size on change in left ventricular mass following aortic valve replacement. Eur J Cardiothorac Surg 1994;8: 293-7 https://doi.org/10.1016/S1010-7940(05)80088-0
  17. Sung K, Park PW, Park KH, Jun TG, Lee YT, Yang JH. Comparison of transprosthetic mean pressure gradients between Medtronic Hall and ATS valves in aortic position. Int J Cardiol 2005;99:29-35 https://doi.org/10.1016/j.ijcard.2003.10.066
  18. Bottio T, Caprili L, Casarotto D, Gerosa G. Small aortic annulus: the hydrodynamic performances of 5 commercially available bileaflet mechanical valves. J Thorac Cardiovasc Surg 2004;128:457-62 https://doi.org/10.1016/j.jtcvs.2004.03.021
  19. Pibarot P, Dumesnil JG, Cartier PC, et al. Patient-prosthesis mismatch can be predicted at the time of operation. Ann Thorac Surg 2001;71:S265-8 https://doi.org/10.1016/S0003-4975(00)02253-0
  20. Penta de Peppo A, Zeitani J, Nardi P, et al. Small 'Functional' size after mechanical aortic valve replacement: no risk in young to middle-age patients. Ann Thorac Surg 2005; 79:1915-22 https://doi.org/10.1016/j.athoracsur.2004.12.001